cer medical device, regulatory writing, & more

Industries We Serve:

Medical Devices/IVDs

Here’s How We Can Help

GLOBAL’s Medical Device and IVD Division is dedicated to supporting your regulatory and compliance needs with a comprehensive suite of services. Our expertise includes:

Medical and Regulatory Writing including CEP/CERs, PMCF & PMS Plans/Reports, PSURs, SSCPs, and Literature Reviews

Project Management including schedule creation and full-service project management of EU MDR Deliverables

Regulatory and Technical Consulting including CER Strategy, PMCF strategy, SOP review, and template review

Training including our regulatory writing internship program, CER Essentials Course, and custom training programs

CER medical device
CER medical device

Delivering Regulatory Services that Make a Real Difference.

Regulatory Writing

Our experienced in-house writers deliver precise, compliant, and high-quality regulatory documents. We offer a full suite of writing services to cover all your document needs.

Consulting Services

Our team's deep industry knowledge and regulatory expertise help you navigate the complex requirements and optimize your regulatory strategies.

Additional Services

We tailor our services to meet the unique needs of each client, providing flexible and scalable solutions.

GLOBAL Resources

Recent Blogs

What Is a 510(k)?

The 510(k) pathway may be well established, but success depends on precision and clarity. With deep experience across medical device categories and FDA submission types, our team at GLOBAL helps you bring safe, effective technologies to patients—faster and with confidence.

READ THE BLOG

What is IVDR?

The In Vitro Diagnostic Regulation (IVDR) (EU 2017/746) is the European Union’s regulatory framework governing in vitro diagnostic medical devices—tests and instruments used to examine human samples like blood or tissue. For manufacturers, understanding the IVDR is essential for maintaining or gaining access to the EU market.

READ THE BLOG

IND vs. NDA: Understanding the Difference in FDA Submissions

For drug developers, FDA approval is a long and complex journey. Two of the most important milestones on this path are the Investigational New Drug (IND) application and the New Drug Application (NDA). While both are critical submissions, they serve very different purposes.

READ THE BLOG

View More Resources from Global

Let’s Get Started

GLOBAL provides trusted regulatory consulting , writing, and technology solutions to help manufacturers bring products to patients at a life saving pace. We’ll be with you every step of the way.

BOOK a CONSULTATION